Trial intelligence / Profile preview

Pregabalin CR in partial onset seizures

NCT01262677Phase 3Completed

Sponsor
Viatris
Start
Feb 2011
Primary completion
Jul 2012
Modality
Small Molecules
Countries
18
01

Overview

A Phase 3 trial of pregabalin in focal onset seizure, sponsored by Viatris. Started Feb 2011; status: completed.

02

Drugs

pregabalin
03

Conditions

focal onset seizure

Beyond the preview

Go deeper on NCT01262677.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01262677.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call